Guidelines on treatment of perinatal depression with antidepressants: An international review

Nina M Molenaar, Astrid M Kamperman, Philip Boyce, Veerle Bergink, Nina M Molenaar, Astrid M Kamperman, Philip Boyce, Veerle Bergink

Abstract

Objective: Several countries have developed Clinical Practice Guidelines regarding treatment of perinatal depressive symptoms and perinatal use of antidepressant. We aimed to compare guidelines to guide clinicians in best clinical practice.

Methods: An extensive search in guideline databases, MEDLINE and PsycINFO was performed. When no guidelines were (publicly) available online, we contacted psychiatric-, obstetric-, perinatal- and mood disorder societies of all first world countries and the five largest second world countries. Only Clinical Practice Guidelines adhering to quality criteria of the Appraisal of Guidelines for Research and Evaluation instrument and including a systematic review of evidence were included. Data extraction focussed on recommendations regarding continuation or withdrawal of antidepressants and preferred treatment in newly depressed patients.

Results: Our initial search resulted in 1094 articles. After first screening, 40 full-text articles were screened. Of these, 24 were excluded for not being an official Clinical Practice Guidelines. In total, 16 Clinical Practice Guidelines were included originating from 12 countries. Eight guidelines were perinatal specific and eight were general guidelines.

Conclusion: During pregnancy, four guidelines advise to continue antidepressants, while there is a lack of evidence supporting this recommendation. Five guidelines do not specifically advise or discourage continuation. For new episodes, guidelines agree on psychotherapy (especially cognitive behavioural therapy) as initial treatment for mild to moderate depression and antidepressants for severe depression, with a preference for sertraline. Paroxetine is not preferred treatment for new episodes but switching antidepressants for ongoing treatment is discouraged (three guidelines). If mothers use antidepressants, observation of the neonate is generally recommended and breastfeeding encouraged.

Keywords: Clinical Practice Guideline; antidepressants; depressive disorder; perinatal depression; pregnancy.

Conflict of interest statement

Declaration of Conflicting Interests: The author(s) declared no potential conflicts of interest with respect to the research, authorship and/or publication of this article.

Figures

Figure 1.
Figure 1.
Flowchart of the article selection process. NGC: National Guideline Clearinghouse; NICE: National Institute for Health and Care Excellence; CMA: Canadian Medical Association Infobase; NHMRC: National Health and Medical Research Council; G-I-N: Guidelines International Network; CPG: Clinical Practice Guideline.

References

    1. ACOG Committee on Practice Bulletins-Obstetrics (2008) Use of psychiatric medications during pregnancy and lactation. Obstetrics and Gynecology 111: 1001–1020.
    1. Alonso J, Angermeyer MC, Bernert S, et al. (2004) Use of mental health services in Europe: Results from the European Study of the Epidemiology of Mental Disorders (ESEMeD) project. Acta Psychiatrica Scandinavica 420: 47–54.
    1. American Psychiatric Association (2010) Practice Guideline for the Treatment of Patients with Major Depressive Disorder, 3rd Edition. Arlington, VA: American Psychiatric Association.
    1. Austin MP, Highet N. and the Expert Working Group (2017) Mental Health Care in the Perinatal Period: Australian Clinical Practice Guideline. Melbourne, VIC, Australia: Centre of Perinatal Excellence.
    1. Bais B, Kamperman AM, van der Zwaag MD, et al. (2016) Bright light therapy in pregnant women with major depressive disorder: Study protocol for a randomized, double-blind, controlled clinical trial. BMC Psychiatry 16: 381.
    1. BC Reproductive Mental Health Program (2014) Best Practice Guidelines for Mental Health Disorders in the Perinatal Period. Vancouver, BC, Canada: BC Reproductive Mental Health.
    1. Bijl RV, Ravelli A. (2000) Psychiatric morbidity, service use, and need for care in the general population: Results of the Netherlands Mental Health Survey and Incidence Study. American Journal of Public Health 90: 602–607.
    1. Bushnell J, McLeod D, Dowell A, et al. (2006) The treatment of common mental health problems in general practice. Family Practice 23: 53–59.
    1. Cohen LS, Altshuler LL, Harlow BL, et al. (2006) Relapse of major depression during pregnancy in women who maintain or discontinue antidepressant treatment. JAMA 295: 499–507.
    1. Dansk Psykiatrisk Selskab, Dansk Selskab for Obstetrik og Gynaekologi, Dansk Paediatrisk Selskab, Dansk Selskab for Klinisk Farmakologi. (2014) Anvendelse af psykofarmaka ved graviditet og amning - kliniske reningslinjer. Edition 27October2014
    1. DGPPN, BÄK, KBV, AWMF (Hrsg.) für die Leitliniengruppe Unipolare Depression (2015). S3-Leitlinie/Nationale Versor-gungsLeitlinie Unipolare Depression - Langfassung, 2. Auflage. Version 5. 2015. [cited: 2018-February-22]. DOI: 10.6101/AZQ/000364 .
    1. Field T. (2011) Prenatal depression effects on early development: A review. Infant Behavior & Development 34: 1–14.
    1. Goodman SH, Rouse MH, Connell AM, et al. (2011) Maternal depression and child psychopathology: A meta-analytic review. Clinical Child and Family Psychology Review 14: 1–27.
    1. Graham R, Mancher M, Wolman DM, et al. (2011) Clinical Practice Guidelines We Can Trust. Washington, DC: National Academies Press.
    1. Grigoriadis S, VonderPorten EH, Mamisashvili L, et al. (2013. a) Antidepressant exposure during pregnancy and congenital malformations: Is there an association? A systematic review and meta-analysis of the best evidence. Journal of Clinical Psychiatry 74: e293–e308.
    1. Grigoriadis S, VonderPorten EH, Mamisashvili L, et al. (2013. b) The effect of prenatal antidepressant exposure on neonatal adaptation: A systematic review and meta-analysis. Journal of Clinical Psychiatry 74: e309–e320.
    1. Grigoriadis S, VonderPorten EH, Mamisashvili L, et al. (2013. c) The impact of maternal depression during pregnancy on perinatal outcomes: A systematic review and meta-analysis. Journal of Clinical Psychiatry 74: e321–e341.
    1. Grote NK, Bridge JA, Gavin AR, et al. (2010) A meta-analysis of depression during pregnancy and the risk of preterm birth, low birth weight, and intrauterine growth restriction. Archives of General Psychiatry 67: 1012–1024.
    1. Howard LM, Kirkwood G, Latinovic R. (2007) Sudden infant death syndrome and maternal depression. Journal of Clinical Psychiatry 68: 1279–1283.
    1. Kasper S, Lehofer M, Doering S, et al. (2012) Depression - Medikametöse Therapie. CliniCum neuropsy. Sonderausgabe November 2012.
    1. Kessler RC, Bromet EJ. (2013) The epidemiology of depression across cultures. Annual Review of Public Health 34: 119–138.
    1. Kieler H, Artama M, Engeland A, et al. (2012) Selective serotonin reuptake inhibitors during pregnancy and risk of persistent pulmonary hypertension in the newborn: Population based cohort study from the five Nordic countries. BMJ 344: d8012.
    1. Kovess-Masfety V, Alonso J, Brugha TS, et al. (2007) Differences in lifetime use of services for mental health problems in six European countries. Psychiatric Services 58: 213–220.
    1. Kruijshaar ME, Barendregt J, Vos T, et al. (2005) Lifetime prevalence estimates of major depression: An indirect estimation method and a quantification of recall bias. European Journal of Epidemiology 20: 103–111.
    1. Li L, Ma X. (2015) Guideline on the Prevention and Treatment of Depressive Disorder in China, 2nd Edition. Beijing, China: Beijing Medical University Press.
    1. Liu X, Agerbo E, Ingstrup KG, et al. (2017) Antidepressant use during pregnancy and psychiatric disorders in offspring: Danish nationwide register based cohort study. BMJ 358: j3668.
    1. MacQueen GM, Frey BN, Ismail Z, et al. (2016) Canadian Network for Mood and Anxiety Treatments (CANMAT) 2016 clinical guidelines for the management of adults with major depressive disorder: Section 6. Special populations – Youth, women, and the elderly. Canadian Journal of Psychiatry 61: 588–603.
    1. Malhi GS, Bassett D, Boyce P, et al. (2015) Royal Australian and New Zealand College of Psychiatrists clinical practice guideline for mood disorders. Australian and New Zealand Journal of Psychiatry 49: 1087–1206.
    1. Management of Major Depressive Disorder Working Group (2016) VA/DoD Clinical Practice Guideline for the Management of Major Depressive Disorder (version 3.0). Washington, DC: Department of Veterans Affairs and Department of Defense.
    1. Ministry of Health (2012) MOH Clinical Practice Guidelines 1/2012 – Depression. Singapore: Ministry of Health.
    1. Ministry of Health, Social Services and Equality (2014) Clinical Practice Guideline on the Management of Depression in Adults: SNS Clinical Practice Guidelines. Madrid: Ministry of Health, Social Services and Equality.
    1. Molenaar NM, Brouwer ME, Bockting CLH, et al. (2016) Stop or go? Preventive cognitive therapy with guided tapering of antidepressants during pregnancy: Study protocol of a pragmatic multicentre non-inferiority randomized controlled trial. BMC Psychiatry 16: 72.
    1. Molyneaux E, Howard LM, McGeown HR, et al. (2014) Antidepressant treatment for postnatal depression. Cochrane Database of Systematic Reviews 11: CD002018.
    1. National Collaborating Centre for Mental Health (2014) Antenatal and Postnatal Mental Health: The NICE Guideline on Clinical Management and Service Guidance. London: British Psychological Society and Royal College of Psychiatrists.
    1. Nederlandse Vereniging voor Obstetrie en Gynaecologie (2012) Richtlijn: SSRI-gebruik in de zwangerschap en tijdens de lactatie. North Padre Island, TX: Nederlandse Vereniging voor Obstetrie en Gynaecologie.
    1. Nordeng H, Jettestad M. (2015) Depression during Pregnancy and Lactation. Oslo: Nordic Federation of Obstetrics and Gynaecology.
    1. Olfson M, Blanco C, Marcus SC. (2016) Treatment of adult depression in the United States. JAMA Internal Medicine 176: 1482–1491.
    1. Piccinelli M, Wilkinson G. (2000) Gender differences in depression: Critical review. British Journal of Psychiatry 177: 486–492.
    1. Pinheiro E, Bogen DL, Hoxha D, et al. (2015) Sertraline and breastfeeding: Review and meta-analysis. Archives of Women’s Mental Health 18: 139–146.
    1. Pratt LA, Brody DJ, Gu Q. (2011) Antidepressant use in persons aged 12 and over: United States, 2005–2008. NCHS Data Brief 76: 1–8.
    1. Ross LE, Grigoriadis S, Mamisashvili L, et al. (2013) Selected pregnancy and delivery outcomes after exposure to antidepressant medication: A systematic review and meta-analysis. JAMA Psychiatry 70: 436–443.
    1. Santos F, Sola I, Rigau D, et al. (2012) Quality assessment of clinical practice guidelines for the prescription of antidepressant drugs during pregnancy. Current Clinical Pharmacology 7: 7–14.
    1. Scottish Intercollegiate Guidelines Network (SIGN) (2012) Management of Perinatal Mood Disorders (Publication no. 127). Edinburgh: SIGN.
    1. Simoncelli M, Martin BZ, Berard A. (2010) Antidepressant use during pregnancy: A critical systematic review of the literature. Current Drug Safety 5: 153–170.
    1. Sleath BL, Rubin RH, Huston SA. (2001) Antidepressant prescribing to Hispanic and non-Hispanic white patients in primary care. Annals of Pharmacotherapy 35: 419–423.
    1. Talge NM, Neal C, Glover V, et al. (2007) Antenatal maternal stress and long-term effects on child neurodevelopment: How and why? J Child Psychol Psychiatry 48: 245–261.
    1. Tronick E, Reck C. (2009) Infants of depressed mothers. Harvard Review of Psychiatry 17: 147–156.
    1. Van Ravesteyn LM, Lambregtse-van den, Berg MP, Hoogendijk WGJ, et al. (2017) Interventions to treat mental disorders during pregnancy: A systematic review and multiple treatment meta-analysis. PLoS ONE 12: e0173397.
    1. Van Weel-Baumgarten EM, Van Gelderen MG, Grundmeijer HGLM, et al. (2012) NHG-Standaard Depressie (tweede herziening). Huisarts Wet 55: 252–259.
    1. Verhaak PF, Prins MA, Spreeuwenberg P, et al. (2009) Receiving treatment for common mental disorders. General Hospital Psychiatry 31: 46–55.
    1. Verhaak PF, van Dijk CE, Nuijen J, et al. (2012) Mental health care as delivered by Dutch general practitioners between 2004 and 2008. Scandinavian Journal of Primary Health Care 30: 156–162.
    1. Vigod S, Hussain-Shamsy N, Grigoriadis S, et al. (2016) A patient decision aid for antidepressant use in pregnancy: Study protocol for a randomized controlled trial. Trials 29: 110–117.
    1. Wang PS, Berglund P, Kessler RC. (2000) Recent care of common mental disorders in the United States: Prevalence and conformance with evidence-based recommendations. Journal of General Internal Medicine 15: 284–292.
    1. Warburton W, Hertzman C, Oberlander TF. (2010) A register study of the impact of stopping third trimester selective serotonin reuptake inhibitor exposure on neonatal health. Acta Psychiatrica Scandinavica 121: 471–479.
    1. Woody CA, Ferrari AJ, Siskind DJ, et al. (2017) A systematic review and meta-regression of the prevalence and incidence of perinatal depression. Journal of Affective Disorders 219: 86–92.
    1. World Health Organization (WHO) (2017) Depression and Other Common Mental Disorders: Global Health Estimates. Geneva: WHO.
    1. Yonkers KA, Gotman N, Smith MV, et al. (2011) Does antidepressant use attenuate the risk of a major depressive episode in pregnancy? Epidemiology 22: 848–854.

Source: PubMed

3
Abonner